When: Q3 FY26 earnings (late October)

Then: Binary reassessment regardless of price

HOLD with modest 20-25% trim into strength at 370; tighten stop to 372; revisit only if price closes below 358.89 on volume or breaks 50 SMA at 345 with confirmation

• 200 SMA: price 9.5% above, strongly bullish medium-term; 50 SMA: price 4.7% above, bullish, rising slope
• Pullback from 374 to 361 over 8 sessions = 3.4% decline, characterized as 'healthy bullish trend' and 'orderly consolidation' per technical report
• MACD: line at 5.6 vs signal at 6.63, both positive, indicating momentum cooling not trend failure
• Volume on down sessions: 7.55 million shares, within Visa's normal 5-8 million range; no panic distribution
• 14.7% run in 90 days; stock at 361, with support at 358.89 and resistance at 374
• Operating margin: Q1 2026 at 67.4%, Q2 2026 at 61.7% (with ~253 million in special charges); 2-quarter decline from 68.3% to 61.7%
• Net margins: 50%; ROE: 61%; elite profitability metrics at current margin level
• Forward P/E: 24.13; expected earnings growth: 27%; PEG: 1.64 (needs 28% growth to justify current price)
• Zacks raised 2026-2027 estimates; analysts who model numbers disagree with bear case
• Macro: US recession probability 8%; Fed hold probability 85%; supports Visa float economics
• DOJ debit case and Hormuz Strait disruption (55% probability) were known risks when stock was at 330 in June; already priced in
• Buyback program: 10 billion plus annually; AAA credit; debt-light cash-rich balance sheet
• Conservative recommendation: sell 20-25% into strength at 370; stop at 372 (1 ATR below entry); exit triggers at 358.89 close on volume or 50 SMA break at 345 with confirmation

→ vs aggressive: Misreads technical setup as reversal; actual report says 'not a reversal,' 'healthy bullish trend,' 'bull-flag,' with 200 SMA 9.5% above price and 50 SMA rising

→ vs aggressive: Cherry-picks margin compression; ignores 253 million in special charges and volume-driven scaling costs in Q2; Q1 2026 margin at 67.4% was normal

→ vs aggressive: Intellectually dishonest valuation framing; PEG of 1.64 with 27% consensus growth is not 64% overvalued; only 1 percentage point below 28% threshold

→ vs aggressive: Hindsight assembly on catalysts; DOJ and Hormuz risks existed in June at 330 and stock rallied 14.7% since; cannot build directional case on risks already priced in

→ vs aggressive: Asymmetry math pre-commits to bear case; 50 SMA is support not resistance in confirmed uptrend; if it holds, downside is 1.4% to 358.89 not 3.5% to 345

→ vs aggressive: Proposing 40-50% position cut on micro-pullback is directional bet dressed as risk management, not discipline; trim with defined stop is proper response to mixed signals

TRIM

• Medium-term uptrend is intact
• Long-term uptrend is intact
• Short-term momentum has cooled
• Margin compression is a real concern requiring monitoring but not yet a confirmed structural break
• Valuation is premium but not extreme
• Catalyst calendar is mixed with slight negative lean
• This is a trim situation, not an underweight situation and not a hold situation
• Q4 2025 gross margin was 68.3%, Q1 2026 was 67.4%, Q2 2026 was 61.7% (includes ~$253M in special charges)
• Actual Q1 to Q2 quarter-over-quarter compression is 570 bps, not the 660 bps peak-to-trough figure
• Consensus forward EPS growth of 27% yields PEG of 1.64—circular reasoning for fair value case
• Hormuz disruption probability moved from 44% to 55% in one week (11 percentage point repricing)
• Stock rallied 14.7% while risks were building, suggesting market absorption rather than risk dissipation
• Conservative analyst's stop at 372 from entry at 370 is only 1/10 ATR (7.87) and will get clipped
• ATR is 7.87; recommended stop of 374 gives half to two-thirds ATR of room
• Buyback run rate is $22 billion annually, supporting structural case
• Record revenue quarter, beat earnings, raised guidance, announced strategic acquisition
• Trim 25-30% on strength into 368-370 zone, keep core position intact
• Re-evaluate if price closes below 358.89 on volume (breaks intraday low)
• Re-evaluate if price closes below 50 SMA at 345 with volume confirmation (regime change trigger)
• Add back on close above 364.52 (10 EMA) on above-average volume with MACD histogram turning positive
• Prior swing high and upper Bollinger band at 374 provides logical stop level

→ vs aggressive: 660 bps margin compression is cherry-picked (Q4 2025 vs Q2 2026); actual Q1 to Q2 move is 570 bps, still meaningful but not the apocalyptic structural break being sold

→ vs aggressive: Q2 2026 margin includes ~$253M in special charges plus elevated network partner incentives—distorted by non-recurring items, not confirmed structural deterioration

→ vs aggressive: Acting before confirmation in a confirmed medium and long-term uptrend with record revenue, beat earnings, raised guidance, and strategic acquisition is directional betting, not discipline

→ vs aggressive: Calling the 50 SMA break in advance with 50-60% benchmark weight reduction risks locking in losses and missing retest of 380 if consolidation resolves normally

→ vs aggressive: 'Act before confirmation is discipline' is a bumper sticker, not a risk framework

→ vs conservative: Using consensus 27% forward EPS growth to argue PEG of 1.64 is fair value is circular reasoning—you're saying the stock is fairly valued because consensus says it is

→ vs conservative: Dismissing DOJ and Hormuz catalysts by pointing to June price at 330 ignores that risks existing for months can resolve at any moment, and Hormuz probability just repriced 11 percentage points in one week

→ vs conservative: Saying market has priced in risks is a hypothesis, not a fact, and post-July 29 price action suggests digestion consistent with risk repricing

→ vs conservative: Stop at 372 from entry at 370 is only 0.25 of ATR (7.87)—essentially guaranteeing a small loss on the trim before the directional thesis has room to play out